
Steering Board
BraineHealth’s Steering Board leads our mission to revolutionize healthcare with US Patent 11,908,579 B2 and Diagnosio’s AI diagnostics.
Comprising experienced founders and managers, this team drives our 99% accurate inversion technology—featured in USA News, BizWeekly and AP across 450+ outlets.
Meet the board below and explore partnership opportunities.
License the Patent to integrate our 99% accurate AI technology.
Contact Us for collaboration.



Roger Svensson, Founder and CEO
Roger is the founder and President of BraineHealth, creator of Diabetio and Diagnosio—AI applications for diabetes care. A serial entrepreneur and former research leader at Karolinska Institutet, he has spun off companies from seed to IPO, including CRAD AB (market cap MSEK 1,087).
Roger is also founder and CEO of Lugn&Ro Sverige AB (70 employees), where Diabetio and Diagnosio were refined. He holds a PhD from Stockholm University/Karolinska Institutet and an MBA from Stockholm School of Economics.
Isabella Svensson, Co-Founder and Program Manager
Isabella is co-founder of BraineHealth, where she manages AI solutions and content development. She was also co-founder and board member of several health care companies and, co-developer of telemedicine solutions.
With experience in project and IT-system management, she has implemented public digital healthcare services like 1177 Vårdguiden in Stockholm County. Isabella holds studies in science theory, culture, and media from Stockholm University.